Political pressure in the Senate
The White House has dropped its nomination of Heidi Overton to lead the Food and Drug Administration, a White House official told the Guardian. This decision follows concerns that Overton, a preventive care doctor who previously served in the Trump White House, lacked sufficient Republican support on the Senate health panel. Senator Bill Cassidy, a Louisiana doctor who chairs the Senate health, labor and pensions committee, said on Tuesday that he remained undecided about her nomination ahead of a committee vote scheduled for Wednesday. Cassidy previously called Overton’s support for Trump’s plan to break up combination vaccines almost disqualifying and pressed her during a September hearing about her scientific independence and willingness to push back against Trump and health secretary Robert F Kennedy Jr. Overton had spent most of her professional career working directly for Trump or conservative groups aligned with his agenda. Trump nominated Overton in August as a move to bring a stabilizing Trump loyalist to the agency after a tumultuous year under Trump’s first FDA commissioner, Marty Makary. The news of her withdrawal was first reported by Axios on Tuesday evening.
Reproductive rights concerns
Reproductive Freedom for All celebrated the White House decision. Mini Timmaraju, the president and CEO of Reproductive Freedom for All, formerly Naral Pro-Choice America, said Overton posed a "serious threat" to the future of medication abortion access. She noted that voters rejected that anti-abortion agenda nationwide and that members kept pressure on to tank her confirmation. Overton would have overseen the agency that regulates medication abortions. In a 2023 policy brief for the America First Policy Institute, Overton said Congress should strictly regulate the abortion pill mifeprestone to protect women and children. She also criticized federal policies that allow the mailing of abortion pills and wrote that abortion "is corrosive to children, women, and society broadly." To win confirmation, Overton needed all 12 Republican votes on the committee. Democrats hold 11 seats on the committee, and without Republican support, Overton faced little chance of winning a full Senate vote. Republicans are racing to confirm all of Trump’s current nominees before they hand over power to Senate Democrats in January.
